Načítá se...

Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme

Genetically engineered variants of human lysozyme represent promising leads in the battle against drug-resistant bacterial pathogens, but early stage development and testing of novel lysozyme variants is constrained by the lack of a robust, scalable and facile expression system. While wild type huma...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lamppa, John W., Tanyos, Sam A., Griswold, Karl E.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594478/
https://ncbi.nlm.nih.gov/pubmed/23220215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiotec.2012.11.007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!